Viewing Study NCT01527435

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:37 PM
Ignite Modification Date: 2026-02-26 @ 5:45 PM
Study NCT ID: NCT01527435
Status: COMPLETED
Last Update Posted: 2016-04-06
First Post: 2012-01-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
Sponsor: The Retina Center of St. Louis County, PC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Exudative Age-Related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Best corrected visual acuity View
None Slit lamp examination View
None Ophthalmoscopy with contact lens/indirect ophthalmoscope View
None OCT assessment View
None Fundus photos, fluorescein angiogram, ICG angiogram View